Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia
在亚洲开展的随机KEYNOTE-181试验中，帕博利珠单抗与化疗在食管鳞状细胞癌患者中的疗效比较。
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100341
Cao, Y; Qin, S; Luo, S; Li, Z; Cheng, Y; Fan, Y; Sun, Y; Yin, X; Yuan, X; Li, W; Liu, T; Hsu, C-H; Lin, X; Kim, S-B; Kojima, T; Zhang, J; Lee, S-H; Bai, Y; Muro, K; Doi, T; Bai, C; Gu, K; Pan, H-M; Bai, L; Yang, J-W; Cui, Y; Lu, W; Chen, J
